Suzhou Basecare Medical Corporation Limited (HKG:2170)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.990
+0.140 (7.57%)
Mar 10, 2026, 3:43 PM HKT
-38.39%
Market Cap 506.02M
Revenue (ttm) 302.12M
Net Income (ttm) -261.45M
Shares Out 273.53M
EPS (ttm) -0.96
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 151,000
Average Volume 159,075
Open 1.850
Previous Close 1.850
Day's Range 1.850 - 2.000
52-Week Range 1.780 - 4.450
Beta 0.25
RSI 46.06
Earnings Date Mar 27, 2026

About HKG:2170

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People’s Republic of China and Australia. The company offers pre-implantation genetic test kits, including PGT-A kit to detect aneuploidy; PGT-M kit to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kit to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also provides DA500, a high-throughput gene sequencer that provi... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2010
Employees 419
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2170
Full Company Profile

Financial Performance

In 2024, HKG:2170's revenue was 299.11 million, an increase of 43.82% compared to the previous year's 207.98 million. Losses were -237.03 million, 23.7% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.